Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
537.3 USD | -0.45% | +1.10% | +13.93% |
Apr. 26 | HCA beats first-quarter profit estimates on higher patient admissions | RE |
Apr. 25 | Elevance Health Insider Sold Shares Worth $10,832,155, According to a Recent SEC Filing | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.83 for the current period. Therefore, the company is undervalued.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Managed Healthcare
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.93% | 125B | A- | ||
+18.37% | 101B | B- | ||
-0.28% | 39.69B | B- | ||
-33.18% | 36.86B | A- | ||
-5.28% | 20.05B | B- | ||
-13.82% | 3.08B | C+ | ||
-39.49% | 993M | B- | ||
-28.58% | 337M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ELV Stock
- Ratings Elevance Health, Inc.